{"id":5081,"date":"2023-10-12T10:36:16","date_gmt":"2023-10-12T10:36:16","guid":{"rendered":"https:\/\/www.katheraugenstein.com\/?post_type=news&#038;p=5081"},"modified":"2023-10-13T10:44:55","modified_gmt":"2023-10-13T10:44:55","slug":"the-pharmaceutical-intellectual-property-and-competition-law-review-update-christopher-weber-and-dr-benjamin-pesch-publish-on-recent-developments-in-intellectual-property-and-competition-law-in-the","status":"publish","type":"news","link":"https:\/\/www.katheraugenstein.com\/en\/news\/the-pharmaceutical-intellectual-property-and-competition-law-review-update-christopher-weber-and-dr-benjamin-pesch-publish-on-recent-developments-in-intellectual-property-and-competition-law-in-the\/","title":{"rendered":"The Pharmaceutical Intellectual Property and Competition Law Review &#8211; Update: Christopher Weber and Dr Benjamin Pesch publish on recent developments in intellectual property and competition law in the pharmaceutical sector in Germany"},"content":{"rendered":"\t<section class=\"section big-visual parallax\" data-parallax-min-screen-width=\"768\">\n\t\t<picture class=\"big-visual__image-container\"><source srcset=\"https:\/\/www.katheraugenstein.com:443\/app\/uploads\/The-Law-Review-2023-Header-1-414x221.png\" width=\"414\" height=\"221\" media=\"(max-width: 414px)\" \/><source srcset=\"https:\/\/www.katheraugenstein.com:443\/app\/uploads\/The-Law-Review-2023-Header-1-767x410.png\" width=\"767\" height=\"410\" media=\"(max-width: 767px)\" \/><img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/www.katheraugenstein.com:443\/app\/uploads\/The-Law-Review-2023-Header-1-1920x650.png\" width=\"1920\" height=\"650\" alt=\"\" class=\"big-visual__image parallax__load-image\" loading=\"edge\" \/><\/picture>\n\t\t<div class=\"big-visual__content-container\">\n\t\t\t<div class=\"big-visual__content parallax__item\" data-parallax-type=\"move\" data-parallax-orientation=\"up\" data-parallax-distance=\"70%\">\n\t\t\t\t<p class=\"big-visual__title \">Latest <strong>News.<\/strong><\/p>\n\t\t\t\t<p class=\"big-visual__text\"><\/p>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/section>\n\n\n\t<section class=\"section text-box text-box--variant-1 \">\n\t\t\t\t\t<h2 class=\"h1\">\t\t\t\t\t<span class=\"subline\">The Pharmaceutical Intellectual Property and Competition Law Review &#8211;  Update:<\/span>\n\t\t\t\t\t\t\t\tChristopher Weber und Dr. Benjamin Pesch publish on recent developments in intellectual property and competition law in the pharmaceutical sector in Germany<\/h2>\n\t\t\n\t\t<p class=\"text--intro\">This latest 4. edition of<strong> The Pharmaceutical Intellectual Property and Competition Law Review<\/strong>, our partner <a href=\"https:\/\/www.katheraugenstein.com\/en\/team\/christopher-weber\/\"><strong>Christopher<\/strong> Weber<\/a> and our counsel <a href=\"https:\/\/www.katheraugenstein.com\/en\/team\/dr-benjamin-pesch\/\"><strong>Dr Benjamin Pesch<\/strong><\/a> have published another chapter on current developments in the German market, based on their expertise in the pharmaceutical sector.<\/p>\n<p>In<strong> Chapter 5<\/strong>, they provide <strong>an update on the general principles and recent developments in intellectual property and competition law in the pharmaceutical sector in Germany.<\/strong> A detailed insight into the German chapter can be found<a href=\"https:\/\/www.katheraugenstein.com:443\/app\/uploads\/Kather-Augenstein_Germany_Chapter_5-in-The-Pharmaceutical-Intellectual-Property-and-Competition-Law-Review-edition-4.pdf\"> here.<\/a><\/p>\n<p>Excerpts of the publication are also published as part of our partnership on <a href=\"https:\/\/www.lexology.com\/indepth\/the-pharmaceutical-intellectual-property-and-competition-law-review\"><strong>Lexology<\/strong><\/a>. If you are interested in a bound copy of the book, please contact our two authors:<\/p>\n<p><strong>weber@katheraugenstein<\/strong><\/p>\n<p><strong>pesch@katheraugenstein<\/strong><\/p>\n<p><strong><a href=\"https:\/\/thelawreviews.co.uk\/title\/the-pharmaceutical-intellectual-property-and-competition-law-review\">The Pharmaceutical Intellectual Property and Competition Law Review<\/a><\/strong>\u00a0is an annual hardcover and online guide covering legal and market developments in key jurisdictions in the pharmaceutical sector worldwide.\u00a0<strong>As an \u201cannual review\u201d, the publication provides a detailed analysis of recent developments in legislation and its interpretation by national authorities around the world and aims to give users an insight into future trends.<\/strong><\/p>\n<h2>About the Law Reviews:<\/h2>\n<p>The Law Reviews is a network of experts covering over 108 areas of law in more than 130 countries worldwide, aimed at practitioners looking beyond their own borders for strategic solutions in foreign jurisdictions.<\/p>\n<p>Progressive thinkers from the world\u2019s leading law firms analyse global legal issues and their business implications. The Law Reviews is an essential resource for lawyers, in-house counsel, governments and corporate executives.<\/p>\n<p>The editors of The Law Reviews are recognised international industry experts in key practice areas.<\/p>\n<p>\u00a0<\/p>\n\t\t\n\t\t\t<\/section>\n","protected":false},"template":"","class_list":["post-5081","news","type-news","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.katheraugenstein.com\/en\/wp-json\/wp\/v2\/news\/5081","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.katheraugenstein.com\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.katheraugenstein.com\/en\/wp-json\/wp\/v2\/types\/news"}],"wp:attachment":[{"href":"https:\/\/www.katheraugenstein.com\/en\/wp-json\/wp\/v2\/media?parent=5081"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}